DEUTSCHE BANK AG\

Bank

Position in LRMR — Larimar Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in LRMR

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$294,090

-$125,003 QoQ

Shares Held

96,423

+3.5% QoQ

Ownership

0.093%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#57

of 163 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 38% Shared 0% None 62%

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. LRMR ranks #216 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc.	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$294,090	96,423	+3.5%	Shares	Defined	2026-08-07
2026-03-31	$419,093	93,132	+170.8%	Shares	Defined	2026-05-06
2025-12-31	$131,025	34,390	-37.5%	Shares	Defined	2026-02-11
2025-09-30	$177,653	55,001	+40.9%	Shares	Defined	2025-11-13
2025-06-30	$112,799	39,031	-2.5%	Shares	Defined	2025-08-12
2025-03-31	$86,078	40,037	-9.1%	Shares	Defined	2025-05-09
2024-12-31	$170,480	44,052	-84.4%	Shares	Defined	2025-06-30
2024-09-30	$1,847,505	282,062	+2.7%	Shares	Defined	2025-06-26
2024-06-30	$1,990,675	274,576	+1.0%	Shares	Defined	2025-06-12
2024-03-31	$2,063,903	271,924	-0.2%	Shares	Defined	2025-06-02
2023-12-31	$1,239,297	272,373	+6.6%	Shares	Defined	2024-02-14
2023-06-30	$800,006	255,593	0.0%	Shares	Defined	2023-08-14
2023-03-31	$1,157,836	255,593	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.